openPR Logo
Press release

Epigenetics Market worth $7.63 billion by 2030, growing at a CAGR of 10.82% - Exclusive Report by 360iResearch

03-04-2024 10:57 AM CET | Health & Medicine

Press release from: 360iResearch

Epigenetics Market | 360iResearch

Epigenetics Market | 360iResearch

The "Epigenetics Market by Product (Enzymes, Instruments & Accessories, Reagents & Kits), Technique (Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction & quantitative Polymerase Chain Reaction), Methods, Application, End User - Global Forecast 2024-2030" report has been added to's offering.

The Global Epigenetics Market to grow from USD 3.71 billion in 2023 to USD 7.63 billion by 2030, at a CAGR of 10.82%.

Request a Free Sample Report @

Epigenetics refers to the analysis of heritable phenotype modifications that do not involve alterations in the DNA sequence. It examines the chemical modifications that occur on DNA and histone proteins, which can affect gene expression without changing the underlying genetic code. These epigenetic changes can be influenced by several factors, including age, environment, and disease state, and they are reversible mechanisms passed down to subsequent generations. Epigenetics provides an additional layer of complexity to the regulation of gene expression, and it has significant implications for our understanding of genetics, development, and inheritance. Applications of epigenetics span from biomedical research to therapeutic interventions. In research, epigenetics offers insights into developmental biology and the etiology of diseases. Clinically, it has implications in cancer treatment, metabolic disorders, and personalized medicine. The primary end-users include academic & research institutes, pharmaceutical & biotech companies, and diagnostic centers. The need for epigenetics is increasing due to substantial growth in the prevalence of chronic and genetic disorders worldwide, favorable governmental initiatives and investments in drug discovery and development, and a growing inclination toward personalized medicines. However, the market faces certain challenges, including the high cost of developing epigenetics technologies, lack of awareness, and limited application of epigenetics, hindering the adoption of epigenetics. Ongoing research and development activities for the advancement of epigenetics and expanding the application of epigenetics in non-oncology fields present potential opportunities for the development of epigenetics.

The epigenetics market in North America has exhibited substantial growth, primarily driven by the United States, attributed to heavy investments in research and development, the robust presence of pharmaceutical and biotechnology companies, and a high incidence rate of chronic diseases such as cancer. In South America, the adoption of epigenetics is in the nascent stage and has a potential for development due to the increasing prevalence of genetic disorders and cancers, and Brazil supports the development of epigenetics with an evolving healthcare sector and growing public awareness about advanced treatments. The APAC region is undergoing a rapid transition in the epigenetics sector due to emerging economies such as China, Japan, and India. China has witnessed a surge in patent filings, indicating strong governmental and private interest in epigenetics. The Japanese government encourages precision medicine, resulting in increased funding for epigenetic research programs. India's participation in epigenetic research is expanding, with an increasing number of collaborations and studies. Europe's epigenetics market is robust, led by countries such as Germany, the UK, and France. Extensive research activities, well-established healthcare systems, and growing investments from the private and public sectors propel the regional development. Additionally, active collaborations between key players and academic institutions support the development of advanced epigenetic therapies. The Middle East region is experiencing gradual progress in epigenetics due to the rising prevalence of conditions such as cancer and the expansion of healthcare infrastructure. The interest in personalized medicine is steadily gaining traction, influencing purchasing patterns. In Africa, the development of epigenetics is in the early stages, with limited research facilities. However, there is potential for expansion with increasing international collaboration in healthcare research.

Market Segmentation & Coverage:

This research report categorizes the Epigenetics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Enzymes, Instruments & Accessories, Reagents & Kits, Service, and Software. The Enzymes is further studied across DNA-Modifying Enzymes and Protein-Modifying Enzymes. The Reagents & Kits is further studied across 5-hmC & 5-mC Analysis Kit, Antibodies, Bisulfite Conversion Kits, ChiP-seq Kits, Histones, and Whole Genome Amplification Kits. The Reagents & Kits commanded largest market share of 24.43% in 2023, followed by Instruments & Accessories.

Based on Technique, market is studied across Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction & quantitative Polymerase Chain Reaction, and Sonication. The Polymerase Chain Reaction & quantitative Polymerase Chain Reaction commanded largest market share of 29.21% in 2023, followed by Mass Spectrometry.

Based on Methods, market is studied across DNA Methylation and Histone Modifications. The DNA Methylation commanded largest market share of 53.93% in 2023, followed by Histone Modifications.

Based on Application, market is studied across Cardiovascular Diseases, Developmental Biology, Immunology, Metabolic Diseases, and Oncology. The Oncology commanded largest market share of 22.08% in 2023, followed by Immunology.

Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies commanded largest market share of 39.23% in 2023, followed by Contract Research Organizations.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.48% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Epigenetics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Epigenetics Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Epigenetics Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Active Motif, Inc., Agilent Technologies, Inc., AstraZeneca PLC, Bayer AG, Bio-Rad Laboratories, Inc., BioCat GmbH by AddLife AB, Bioneer Corporation, BPS Bioscience, Inc., Bristol-Myers Squibb Company, Cambridge Epigenetix Ltd., Chroma Medicine, Inc., Creative Biogene, Creative Diagnostics, Cusabio Technology LLC, Diagenode S.A. by Hologic, Inc., Elysium Health, Inc., EpiCypher, Inc., Epigenic Therapeutics, EpiGentek Group Inc., Eurofins Scientific SE, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Fios Genomics Ltd., FOXO Technologies Inc., GenomeScan, GenScript Biotech Corporation, Gilead Sciences, Inc., Illumina, Inc., Integrated DNA Technologies, Inc. by Danaher Corporation, Ipsen, Lonza Group Ltd., Merck KGaA, MorphoSys AG, New England Biolabs, Inc., Novogene Co, Ltd., Omega Therapeutics, Inc., Pacific Biosciences of California, Inc, PerkinElmer, Inc., Promega Corporation, ProteoGenix SAS, Qiagen N.V., Sound Agriculture Company, STORM Therapeutics LTD, Takara Holdings Inc., Thermo Fisher Scientific Inc., Twist Bioscience Corporation, Watchmaker Genomics, Inc., Zenith Epigenetics Ltd., and Zymo Research Corporation.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Epigenetics Market, by Product
7. Epigenetics Market, by Technique
8. Epigenetics Market, by Methods
9. Epigenetics Market, by Application
10. Epigenetics Market, by End User
11. Americas Epigenetics Market
12. Asia-Pacific Epigenetics Market
13. Europe, Middle East & Africa Epigenetics Market
14. Competitive Landscape
15. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Epigenetics Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Epigenetics Market?
3. What is the competitive strategic window for opportunities in the Epigenetics Market?
4. What are the technology trends and regulatory frameworks in the Epigenetics Market?
5. What is the market share of the leading vendors in the Epigenetics Market?
6. What modes and strategic moves are considered suitable for entering the Epigenetics Market?

Read More @

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epigenetics Market worth $7.63 billion by 2030, growing at a CAGR of 10.82% - Exclusive Report by 360iResearch here

News-ID: 3409547 • Views:

More Releases from 360iResearch

Cognitive Systems Market worth $78.39 billion by 2030, growing at a CAGR of 9.39% - Exclusive Report by 360iResearch
Cognitive Systems Market worth $78.39 billion by 2030, growing at a CAGR of 9.39 …
The "Cognitive Systems Market by Components (Services, Software), Applications (BFSI, Healthcare, IT & Telecommunications) - Global Forecast 2024-2030" report has been added to's offering. Request a Free Sample Report @ "Rapid Growth in Cognitive Systems Market Driven by Technological and Regulatory Support" The cognitive systems market is experiencing significant growth fueled by increasing product demand, supportive regulatory policies, and an expanding array of end-user applications. Businesses across various sectors, including healthcare,
DNA Repair Drugs Market worth $13.97 billion by 2030, growing at a CAGR of 7.20% - Exclusive Report by 360iResearch
DNA Repair Drugs Market worth $13.97 billion by 2030, growing at a CAGR of 7.20% …
The "DNA Repair Drugs Market by Drug Type (Alkylating Agents, Poly ADP Ribose Polymerase Inhibitors), Form (Capsules, Injectables, Tablets), Mechanism of Action, Application, Distribution Channel - Global Forecast 2024-2030" report has been added to's offering. Request a Free Sample Report @ "Drivers of Growth in the DNA Repair Drugs Market: Precision Medicine, Regulatory Support, and Increased Demand" The market for DNA repair drugs is experiencing significant growth, driven by a confluence
Chia Seeds Market worth $685.16 million by 2030, growing at a CAGR of 8.43% - Exclusive Report by 360iResearch
Chia Seeds Market worth $685.16 million by 2030, growing at a CAGR of 8.43% - Ex …
The "Chia Seeds Market by Product (Black Chia Seeds, White Chia Seeds), Form (Grounded, Whole), Application, Distribution Channel - Global Forecast 2024-2030" report has been added to's offering. Request a Free Sample Report @ "Rising Demand for Chia Seeds Fueled by Health Awareness, Regulatory Support, and E-commerce Growth" Chia seeds are witnessing a surge in popularity driven by rising consumer awareness of their substantial health benefits, including being rich in omega-3
Chestnuts Market worth $3.94 billion by 2030, growing at a CAGR of 4.39% - Exclusive Report by 360iResearch
Chestnuts Market worth $3.94 billion by 2030, growing at a CAGR of 4.39% - Exclu …
The "Chestnuts Market by Type (American Chestnuts, Chinese Chestnuts, European Chestnuts), Forms (Dried, Fresh, Frozen), Application, Distribution Channel - Global Forecast 2024-2030" report has been added to's offering. Request a Free Sample Report @ "Global Surge in Chestnut Demand Driven by Health Trends and Strategic Market Developments" The rising consumer demand for nutritious foods is boosting the popularity of chestnuts, known for their rich content of vitamins, minerals, and antioxidants. Growing

All 5 Releases

More Releases for Epigenetics

Epigenetics Diagnostic Market Size - Forecasts to 2026
The findings reviewed by GME stated that the Global Epigenetics Diagnostic Market will expand with a CAGR value of 18.8 percent from 2021 to 2026. The growth of the market is attributed to the industry's high technical momentum, i.e. for example, the development of new epigenetic drugs and effective diagnostic tools in both developed and developing nations. Browse the Report @ By Product (Reagents, Kits, Instruments, Enzymes, Services), By Technology (DNA
Epigenetics Diagnostic Market Share by 2025: QY Research
In its recently published report, QY Research has provided unique insights about global Epigenetics Diagnostic market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments of the global Epigenetics Diagnostic market. The scope
Epigenetics Market Prevalent Opportunities upto 2018 to 2028
Global Epigenetics Market: Snapshot The global epigenetics drugs and diagnostic technologies market has witnessed huge traction in the past few years with the emergence of novel drugs and more efficient, next-generation diagnostic technologies. The widespread global research aimed at examining the role of epigenetics in several diseases in humans is the chief factor fueling the market. The term epigenetics refers to the transmissible changes in the expression of genes that does not
Epigenetics Market Objectives and Detailed Study 2018
WiseGuyReports.Com Publish a New Market Research Report On –“ Epigenetics Market Objectives and Detailed Study 2018”. The Epigenetics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Epigenetics market size to maintain the average annual growth rate of 14.47% from 570 million $ in 2014 to 855 million $ in 2017, The analysts believe that in the next few years, Epigenetics market
Epigenetics Market: Restraint,Competitor
Increasing research to study the epigenetics of the genome (study called epigenomics) is expected to boost growth of the epigenetics market over the forecast period. Genome-wide epigenetic studies play an important role in the diagnostics of human diseases. Moreover, implementation of epigenetics for oncology research is estimated to propel the growth of epigenetics market. For instance, Constellation Pharmaceuticals, in April 2018, invested US$ 100 million for development of cancer epigenetics
Epigenetics Market - Development of therapeutic drugs 2025
Global Epigenetics Market: Overview The global epigenetics market is expected to grow at a fast paced CAGR in the next few years, owing to factors such as extensive use in the research of developmental and disease process, and growing importance of Life Science. Increasing incidences of cancer and other life threatening diseases will also drive the growth of the global epigenetics market. Epigenetic changes are extensively used in cancer research for